Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.

Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS.

PLoS One. 2019 Jul 10;14(7):e0219469. doi: 10.1371/journal.pone.0219469. eCollection 2019.

2.

Adjuvant Therapy for Ampullary Cancer.

Ko AH, Nakakura EK.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1171. [Epub ahead of print] No abstract available.

PMID:
31141140
3.

Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases.

Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K.

Pancreas. 2019 Apr;48(4):496-503. doi: 10.1097/MPA.0000000000001271.

PMID:
30946246
4.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
5.

Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases.

Donner DB, Ruan DT, Toriguchi K, Bergsland EK, Nakakura EK, Lin MH, Antonia RJ, Warren RS.

Transl Oncol. 2019 Mar;12(3):550-560. doi: 10.1016/j.tranon.2018.12.007. Epub 2019 Jan 9.

6.

A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.

Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK.

Mol Cancer Ther. 2018 Dec;17(12):2702-2709. doi: 10.1158/1535-7163.MCT-17-1204. Epub 2018 Sep 25.

PMID:
30254185
7.

Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization?

Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE.

Am J Surg Pathol. 2019 Mar;43(3):334-340. doi: 10.1097/PAS.0000000000001152.

PMID:
30211728
8.

Outcomes of arterial bypass preceding resection of retroperitoneal masses involving major vessels.

Luu HY, Wang ED, Syed SM, Xu X, Hansen SL, Eichler CM, Nakakura EK.

J Surg Res. 2018 Oct;230:34-39. doi: 10.1016/j.jss.2018.04.039. Epub 2018 May 15.

PMID:
30100037
9.

Progress in the March to Precision Cancer Medicine: Left, Right, Left.

Nakakura EK.

JAMA Surg. 2018 Jan 1;153(1):67-68. doi: 10.1001/jamasurg.2017.3895. No abstract available.

PMID:
28975234
10.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
11.

Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix.

Nakakura EK.

Ann Surg Oncol. 2018 Mar;25(3):591-593. doi: 10.1245/s10434-017-6026-9. Epub 2017 Aug 4. No abstract available.

PMID:
28779367
13.

The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF.

Pancreas. 2017 Jul;46(6):715-731. doi: 10.1097/MPA.0000000000000846. Review.

14.

Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.

Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK.

Pancreas. 2017 Mar;46(3):416-426. doi: 10.1097/MPA.0000000000000770. Review.

PMID:
28187108
15.

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH.

J Surg Oncol. 2016 Oct;114(5):587-596. doi: 10.1002/jso.24375. Epub 2016 Jul 21.

PMID:
27444658
16.

Finding the Common Thread in Rare Diseases.

Nakakura EK.

JAMA Surg. 2016 Apr;151(4):355. doi: 10.1001/jamasurg.2015.4215. No abstract available.

PMID:
26630540
17.

Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging.

Hope TA, Verdin EF, Bergsland EK, Ohliger MA, Corvera CU, Nakakura EK.

EJNMMI Phys. 2015 Dec;2(1):21. doi: 10.1186/s40658-015-0125-0. Epub 2015 Sep 18.

18.

Solid pseudopapillary neoplasm of the pancreas head in a pregnant woman: safe pancreaticoduodenectomy postpartum.

Yee AM, Kelly BG, Gonzalez-Velez JM, Nakakura EK.

J Surg Case Rep. 2015 Aug 20;2015(8). pii: rjv108. doi: 10.1093/jscr/rjv108.

19.

A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Walker EJ, Simko JP, Nakakura EK, Ko AH.

J Gastrointest Oncol. 2014 Dec;5(6):E88-95. doi: 10.3978/j.issn.2078-6891.2014.051.

20.

Bone metastases and skeletal-related events from neuroendocrine tumors.

Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK.

Endocr Connect. 2015 Mar;4(1):9-17. doi: 10.1530/EC-14-0119. Epub 2014 Nov 27.

21.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441
22.

Neuroendocrine tumors of unknown primary: is the primary site really not known?

Bergsland EK, Nakakura EK.

JAMA Surg. 2014 Sep;149(9):889-90. doi: 10.1001/jamasurg.2014.216. No abstract available.

PMID:
25029597
23.

Time to put another surgical dogma to sleep?

Nakakura EK.

JAMA Surg. 2014 May;149(5):466. No abstract available.

PMID:
24647825
24.

Home, sweet home, after surgery.

Nakakura EK.

JAMA Surg. 2014 Mar;149(3):251. doi: 10.1001/jamasurg.2013.3845. No abstract available.

PMID:
24429807
25.

Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH, Hann B, Nakakura EK, Bergsland EK, Donner DB, Settleman J, Shokat KM, Warren RS.

Oncogene. 2014 Mar 20;33(12):1590-600. doi: 10.1038/onc.2013.92. Epub 2013 Apr 1.

26.

Reply to P.H. Sugarbaker.

Nakakura EK.

J Clin Oncol. 2013 Jan 20;31(3):397-8. No abstract available.

PMID:
23451355
27.

Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.

Wang SC, Fidelman N, Nakakura EK.

Semin Oncol. 2013 Feb;40(1):69-74. doi: 10.1053/j.seminoncol.2012.11.007. Review.

PMID:
23391114
28.

Can CT features differentiate between inferior vena cava leiomyosarcomas and primary retroperitoneal masses?

Webb EM, Wang ZJ, Westphalen AC, Nakakura EK, Coakley FV, Yeh BM.

AJR Am J Roentgenol. 2013 Jan;200(1):205-9. doi: 10.2214/AJR.11.7476.

PMID:
23255763
29.

Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.

Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK.

Pancreas. 2012 Aug;41(6):840-4. doi: 10.1097/MPA.0b013e31823cdaa0.

PMID:
22781907
30.

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13.

31.

Pseudomyxoma peritonei: more questions than answers.

Nakakura EK.

J Clin Oncol. 2012 Jul 10;30(20):2429-30. doi: 10.1200/JCO.2012.42.3764. Epub 2012 May 21. No abstract available.

PMID:
22614983
32.

Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures.

Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK.

World J Surg Oncol. 2011 Nov 4;9:143. doi: 10.1186/1477-7819-9-143.

33.

Unique patterns of metastases in common and rare types of malignancy.

Leong SP, Nakakura EK, Pollock R, Choti MA, Morton DL, Henner WD, Lal A, Pillai R, Clark OH, Cady B.

J Surg Oncol. 2011 May 1;103(6):607-14. doi: 10.1002/jso.21841. Review.

PMID:
21480255
34.

Pancreatic adenocarcinoma.

Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW 2nd, Malafa MP, Muscarella P 2nd, Nakakura EK, Sasson AR, Thayer SP, Tyler DS, Warren RS, Whiting S, Willett C, Wolff RA; NCCN Pancreatic Adenocarcinoma.

J Natl Compr Canc Netw. 2010 Sep;8(9):972-1017. No abstract available.

35.

Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.

Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK.

J Surg Res. 2010 Sep;163(1):47-51. doi: 10.1016/j.jss.2010.04.018. Epub 2010 May 6.

PMID:
20599218
36.

Arterial embolization for the management of gastrointestinal hemorrhage from metastatic renal cell carcinoma.

Fidelman N, Freed RC, Nakakura EK, Rosenberg J, Bloom AI.

J Vasc Interv Radiol. 2010 May;21(5):741-4. doi: 10.1016/j.jvir.2010.01.018. Epub 2010 Mar 20.

PMID:
20304675
37.

Identification of unknown primary tumors in patients with neuroendocrine liver metastases.

Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK.

Arch Surg. 2010 Mar;145(3):276-80. doi: 10.1001/archsurg.2010.10.

PMID:
20231629
38.

The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.

Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK.

Endocr Relat Cancer. 2010 Feb 18;17(1):283-91. doi: 10.1677/ERC-09-0243. Print 2010 Mar.

PMID:
20048018
39.

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D.

Genes Dev. 2009 Sep 15;23(18):2152-65. doi: 10.1101/gad.1820109.

40.

Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.

Wang YC, Gallego-Arteche E, Iezza G, Yuan X, Matli MR, Choo SP, Zuraek MB, Gogia R, Lynn FC, German MS, Bergsland EK, Donner DB, Warren RS, Nakakura EK.

Endocr Relat Cancer. 2009 Mar;16(1):267-79. doi: 10.1677/ERC-08-0127. Epub 2008 Nov 5.

PMID:
18987169
41.

Compound muscle action potentials and spontaneous electromyography can be used to identify and protect the femoral nerve during resection of large retroperitoneal tumors.

Guo L, Clark JP 3rd, Warren RS, Nakakura EK.

Ann Surg Oncol. 2008 Jun;15(6):1594-9. doi: 10.1245/s10434-008-9903-4. Epub 2008 Apr 12.

PMID:
18408974
42.

Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.

Horvai AE, Schaefer JT, Nakakura EK, O'Donnell RJ.

Mod Pathol. 2008 May;21(5):517-24. doi: 10.1038/modpathol.3801017. Epub 2008 Jan 18.

43.

Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.

Tempero M, Arnoletti JP, Ben-Josef E, Bhargava P, Casper ES, Kim P, Malafa MP, Nakakura EK, Shibata S, Talamonti M, Wang H, Willett C.

J Natl Compr Canc Netw. 2007 Nov;5(10):998-1033. Review. No abstract available.

PMID:
18053426
44.

Introduction.

Warren RS, Nakakura EK.

Surg Oncol. 2007 Dec;16(4):235. Epub 2007 Nov 26. No abstract available.

PMID:
18035535
45.

Palliative care for patients with advanced pancreatic and biliary cancers.

Nakakura EK, Warren RS.

Surg Oncol. 2007 Dec;16(4):293-7. Epub 2007 Sep 14. Review.

PMID:
17855076
46.

Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?

Nakakura EK, Venook AP, Bergsland EK.

Surg Oncol Clin N Am. 2007 Jul;16(3):639-51, x. Review.

PMID:
17606198
47.

Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.

Nakakura EK, Bergsland EK.

Hematol Oncol Clin North Am. 2007 Jun;21(3):457-73; viii. Review.

PMID:
17548034
48.

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.

Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD.

Cancer Res. 2006 Aug 1;66(15):7509-15.

49.

Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.

Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW.

J Clin Endocrinol Metab. 2005 Jul;90(7):4350-6. Epub 2005 May 3.

PMID:
15870121
50.

Notch signaling induces rapid degradation of achaete-scute homolog 1.

Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW.

Mol Cell Biol. 2002 May;22(9):3129-39.

Supplemental Content

Loading ...
Support Center